Cargando…
Understanding and Prevention of “Therapy-” Induced Dyskinesias
L-dopa is the most effective, currently available treatment for Parkinson's disease (PD), but it leads to the development of involuntary movements known as L-dopa-induced dyskinesia (LID) in the majority of patients after long-term use. Both gene and cell therapy approaches are the subject of m...
Autores principales: | Aviles-Olmos, Iciar, Kefalopoulou, Zinovia, Foltynie, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3366244/ https://www.ncbi.nlm.nih.gov/pubmed/22685687 http://dx.doi.org/10.1155/2012/640815 |
Ejemplares similares
-
Critical Aspects of Clinical Trial Design for Novel Cell and Gene Therapies
por: Kefalopoulou, Zinovia, et al.
Publicado: (2011) -
Long-term outcome of subthalamic nucleus deep brain stimulation for Parkinson's disease using an MRI-guided and MRI-verified approach
por: Aviles-Olmos, Iciar, et al.
Publicado: (2014) -
Genotype and phenotype in Parkinson's disease: Lessons in heterogeneity from deep brain stimulation
por: Angeli, Aikaterina, et al.
Publicado: (2013) -
Subthalamic nucleus deep brain stimulation induces impulsive action when patients with Parkinson’s disease act under speed pressure
por: Pote, Inês, et al.
Publicado: (2016) -
Inhibitory Control on a Stop Signal Task in Tourette Syndrome before and after Deep Brain Stimulation of the Internal Segment of the Globus Pallidus
por: Morreale, Francesca, et al.
Publicado: (2021)